Cargando…
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Many nations are pursuing the rollout of SARS-CoV-2 vaccines as an exit strategy from unprecedented COVID-19-related restrictions. However, the success of this strategy relies critically on the duration of protective immunity resulting from both natural infection and vaccination. SARS-CoV-2 infectio...
Autores principales: | Milne, Gregory, Hames, Thomas, Scotton, Chris, Gent, Nick, Johnsen, Alexander, Anderson, Roy M, Ward, Tom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530467/ https://www.ncbi.nlm.nih.gov/pubmed/34688434 http://dx.doi.org/10.1016/S2213-2600(21)00407-0 |
Ejemplares similares
-
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020) -
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
por: Dal-Ré, Rafael, et al.
Publicado: (2022) -
The potential of rapalogs to enhance resilience against SARS-CoV-2 infection and reduce the severity of COVID-19
por: Bischof, Evelyne, et al.
Publicado: (2021) -
The bullwhip effect, T-cell telomeres, and SARS-CoV-2
por: Aviv, Abraham
Publicado: (2022) -
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
por: Mostaghimi, Darius, et al.
Publicado: (2022)